Opendata, web and dolomites
H2020 projects about "leukemia"
The page lists 72 projects related to the topic "leukemia".
| # | |||
|---|---|---|---|
| 1 | ApoptoMDS | Hematopoietic stem cell Apoptosis in bone marrow failure and MyeloDysplastic Syndromes: Friend or foe? | 2015 |
| 2 | NovLeuReg | Identification and characterization of novel essential regulators of acute myeloid leukemia | 2016 |
| 3 | SENSITIVITYMARKERS | Clinical validation of prognostic biomarkers of chemotherapy response in liquid biopsies | 2015 |
| 4 | Diricore | Exploiting vulnerabilities in protein synthesis for cancer diagnosis and therapy | 2015 |
| 5 | ONCOMECHAML | Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia | 2015 |
| 6 | PNANOMED | Personalized Nanomedicines for Leukemia Patients | 2015 |
| 7 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 8 | HemNichMDS | Functional and Molecular Analyses of the Interplay between Hematopoietic and Mesenchymal Niche Cells in Human Myelodysplastic Syndromes. | 2015 |
| 9 | COMAL | COMAL:COhesin Mutations in Acute Leukemia: from modeling and mechanisms to novel therapeutics | 2015 |
| 10 | UNEXPECTED | Uncovering targets for ex vivo expansion of hematopoietic stem cells to enhance cell therapies of blood disorders | 2015 |
| 11 | IL7sigNETure | IL-7/IL-7R signaling networks in health and malignancy | 2015 |
| 12 | M-Imm | Novel etiology of autoimmune disorders: the role of acquired somatic mutations in lymphoid cells | 2015 |
| 13 | LeukoPredict | LeukoPredict: an in vitro system predicting and monitoring the therapeutic response of patients in the cure of Chronic Myeloid Leukemia (CML). | 2016 |
| 14 | INFANTLEUKEMIA | GENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OFINFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA | 2016 |
| 15 | MEDLEM | Cost-effective microfluidic electronic devices for optimal drug administration based on fractional pharmacokinetics for leukemia treatments | 2016 |
| 16 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
| 17 | CLLassify | Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia | 2016 |
| 18 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 19 | NVHSC | Neurovascular interplay in the hematopoietic stem cell niches in homeostasis and myeloproliferative neoplasias | 2016 |
| 20 | EpigenomeProgramming | An experimental and bioinformatic toolbox for functional epigenomics and its application to epigenetically making and breaking a cancer cell | 2016 |
| 21 | HEAL-BY-MIRNA | microRNA replacement therapy for mature B cell neoplasias | 2016 |
| 22 | MARS | Mechanism of allosteric regulation of SHP2 phosphatase and its role in cancer and geneticdiseases: a multidisciplinary computational, structural and biological approach | 2017 |
| 23 | HOXA9 degradome | Deciphering the machinery involved in stability of the transcription factor HOXA9. | 2016 |
| 24 | Oncosmart | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2016 |
| 25 | SCUBA CANCERS | Finding the genetic causes of contagious metastases under the sea | 2017 |
| 26 | MAMLE | Understanding the mechanisms of human acute myeloid leukaemia (AML) evolution | 2017 |
| 27 | LEUKEMIC-TEs | Unveiling the signature of transposable elements-derived transcripts – the transposcriptome – as a biomarker in human acute myeloid leukemia | 2017 |
| 28 | EwiSarc | A novel in vivo platform to study and target undruggable Ewing onco-chimera. | 2017 |
| 29 | CATRATS | Catalytic Enantioselective Allene Cycloisomerisation Reactions for Alkaloid Total Synthesis | 2017 |
| 30 | HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 | 2017 |
| 31 | METCLL | Discovery and validation of ‘epidrivers’ of cancer evolution and resistance to therapy | 2018 |
| 32 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
| 33 | ContraNPM1AML | Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia | 2017 |
| 34 | iAML-lncTARGET | Targeting the transcriptional landscape in infant AML | 2017 |
| 35 | TREAT-NPM1-AML | Improving therapy of NPM1-mutated AML | 2017 |
| 36 | bloodANDbone | Blood and bone – conjoined twins in health and disease: bone marrow analogs for hematological and musculoskeletal diseases | 2018 |
| 37 | AltCheM | In vivo functional screens to decipher mechanisms of stochastically- and mutationally-induced chemoresistance in Acute Myeloid Leukemia | 2018 |
| 38 | CanBioSe | Novel 1D photonic metal oxide nanostructures for early stage cancer detection | 2018 |
| 39 | CLLCLONE | Harnessing clonal evolution in chronic lymphocytic leukemia | 2018 |
| 40 | TET2rec | Mechanisms of TET2 DNA demethylase recruitment to specific genomic regions | 2018 |
| 41 | CHROMABOLISM | Chromatin-localized central metabolism regulating gene expression and cell identity | 2018 |
| 42 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 43 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 44 | REPTOL | Pre-leukemic B cell repertoire alterations in patients with familial chronic lymphocytic leukemia: looking for evidence of a genetically-inherited defect in tolerance induction | 2019 |
| 45 | InTheMLLrBALL | Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia | 2018 |
| 46 | IGpath | Dissecting the functional pathways of B cell receptor immunoglobulin in antigen driven mature B cell lymphomas | 2018 |
| 47 | CARAMBA | SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease | 2018 |
| 48 | LapIt | Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells | 2019 |
| 49 | ONCOSMART | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2018 |
| 50 | KlotoDx | KlotoDx A quick and cost-effective near-patient tool to identify sepsis-related bacteria and antibiotic resistances | 2018 |
| 51 | BloodVariome | Genetic variation exposes regulators of blood cell formation in vivo in humans | 2018 |
| 52 | LeukemiaEnviron | SIGNALING PROPENSITY IN THE MICROENVIRONMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA | 2019 |
| 53 | TALE | Therapeutic Allele Engineering: A novel technology for cell therapy | 2019 |
| 54 | scTALLmap | Single-cell map of the composition and evolution of T-cell acute lymphoblastic leukemia | 2019 |
| 55 | SyLeNCe | Synapses between Leukaemia and its Neighbouring Cells | 2020 |
| 56 | BCLLatlas | Single-cell genomics to comprehensively understand healthy B-cell maturation and transformation to chronic lymphocytic leukemia | 2019 |
| 57 | Exh-Res-CART | Exhaustion-resistant CAR-T cells for the treatment of solid tumours | 2019 |
| 58 | PhotoStem | Photoswitching molecules for the spatiotemporal control of cancer stem cells with light | 2019 |
| 59 | IDEAL | Inhibitor of DUX4-IGH to Erase Acute lymphoblastic Leukaemia | 2020 |
| 60 | PMLingAML | Using PML nuclear body biology to identify potential AML treatment targets | 2020 |
| 61 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
| 62 | Mitobetes | The role of Von Willebrand Domain-containing Protein 8 in mitochondrial physiology | 2020 |
| 63 | ARCH | AGE-RELATED CHANGES IN HEMATOPOIESIS | 2019 |
| 64 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 65 | SLAM-Dx | Diagnostic drug response-profiling using SLAMseq | 2019 |
| 66 | M6AQuantKit | Development and commercialization of kit for quantitative interrogation of a key RNA modification | 2020 |
| 67 | PreventALL | Prevention of childhood Acute Lymphoblastic Leukemia immunology links oncology | 2020 |
| 68 | RECOBIN-PROTACs | Reversible Covalently Binding PROTACs Technology for Protein Degradation in Cancer Therapy | 2020 |
| 69 | LINKER | Elucidating transcriptional rewiring on hematological malignancies via computational methods | 2020 |
| 70 | Hemstem | Targeting leukaemia by modulating hematopoietic stem cell competitiveness | 2020 |
| 71 | ChRONAM-H | Chromatin Regulation Of Normal And Malignant Haematopoiesis | 2020 |
| 72 | Catenin-Condensation | The effect of β-catenin condensation on the Wnt-pathway | 2020 |